Role of CRISPR-Cas Systems in the Pathogenesis of Periodontal Disease and Precision Periodontal Therapy

The advent of CRISPR-Cas systems has ushered in a transformative era in biomedical research, particularly regarding complex diseases such as periodontal disease. This multifaceted condition is driven by a combination of microbial dysbiosis and host immune responses, leading to a progressive inflammatory state that can culminate in tooth loss if not managed effectively. Recent investigations have highlighted the potential of CRISPR technology to address these underlying causes by targeting specific microbial elements and modulating host responses. The integration of CRISPR-Cas systems into precision periodontal therapy not only promises a tailored approach to treatment but also raises pertinent questions regarding the ethical considerations and technical limitations associated with gene editing. Thus, this exploration aims to elucidate the intricate role of CRISPR-Cas systems in the pathogenesis of periodontal disease while also assessing their therapeutic potential and implications for future clinical applications.